Clinical Trials

Aspergillosis

Displaying 2 studies

A Registry Of Antifungal Therapy In Adults With Either Invasive Mucormycosis Or Invasive Aspergillosis Rochester, MN

The objective is to obtain and report outcome data for adult subjects who received systemic antifungal therapy (AFT) for the treatment of invasive mucormycosis (IM) or invasive aspergillosis (IA) caused by a non-fumigatus species.
Safety And Efficacy Of PC945 (Opelconazole) In Combination With Other Antifungal Therapy For The Treatment Of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) Jacksonville, FL

The purpose of this study is to assess the effectiveness of nebulized PC945 in combination with systemic antifungal therapy for the treatment of refractory Invasive Pulmonary Aspergillosis (IPA).